ENTITY
BeiGene

BeiGene (BGNE US)

127
Analysis
Health CareChina
BeiGene, Ltd. operates as a commercial stage biopharmaceutical company. The Company focuses on discovery, development, and commercialization of molecularly targeted and immuno-oncology drugs for the treatment of cancer. BeiGene serves patients worldwide.
more
Refresh
Company Presentation09 Nov 2023 19:00
Company Presentation18 Jul 2023 20:30
Company Presentation11 Jul 2019 12:30
Company Presentation11 Jul 2019 12:30
No more presentations
x